Applied Therapeutics (APLT) Return on Assets (2023 - 2025)
Historic Return on Assets for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to 2.69%.
- Applied Therapeutics' Return on Assets fell 19200.0% to 2.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.69%, marking a year-over-year decrease of 19200.0%. This contributed to the annual value of 1.42% for FY2024, which is N/A changed from last year.
- Applied Therapeutics' Return on Assets amounted to 2.69% in Q3 2025, which was down 19200.0% from 2.29% recorded in Q2 2025.
- Over the past 5 years, Applied Therapeutics' Return on Assets peaked at 0.55% during Q2 2024, and registered a low of 2.69% during Q3 2025.
- In the last 3 years, Applied Therapeutics' Return on Assets had a median value of 1.15% in 2023 and averaged 1.35%.
- Per our database at Business Quant, Applied Therapeutics' Return on Assets soared by 2200bps in 2024 and then plummeted by -19200bps in 2025.
- Applied Therapeutics' Return on Assets (Quarter) stood at 1.26% in 2023, then grew by 17bps to 1.04% in 2024, then tumbled by -158bps to 2.69% in 2025.
- Its Return on Assets was 2.69% in Q3 2025, compared to 2.29% in Q2 2025 and 1.46% in Q1 2025.